missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 30161694

GM-CSFR alpha Antibody (mavrilimumab) [Janelia Fluor™ 669], Novus Biologicals™

Human Monoclonal Antibody

Brand:  Novus Biologicals (Bio-Techne) NBP3-28860JF669

Product Code. 30161694

  • £336.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

GM-CSFR alpha Monoclonal antibody specifically detects GM-CSFR alpha in Human samples. It is validated for Flow Cytometry,ELISA,Functional Assay
TRUSTED_SUSTAINABILITY
Specifications

Specifications

GM-CSFR alpha
Monoclonal
Janelia Fluor 669
CD116, CD116 antigen, CDw116, colony stimulating factor 2 receptor alpha subunit, colony stimulating factor 2 receptor, alpha, low-affinity(granulocyte-macrophage), CSF2R, CSF2RAX, CSF2RAY, CSF2RX, CSF2RY, GM-CSF receptor alpha subunit, GMCSFR, GM-CSF-R-alpha, GMCSFR-alpha, GMR, GMR-alpha, granulocyte-macrophage colony-stimulating factor receptor alpha chain, granulocyte-macrophage colony-stimulating factor receptor subunit alpha, MGC3848, MGC4838
CSF2Ra/ GM-CSFRa/ CD116
0.1 mL
Cancer
1438
Store at 4°C in the dark.
IgG4
Flow Cytometry, ELISA, Functional Assay
mavrilimumab
50mM Sodium Borate
Human
Protein A purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.